Moreover, besides the previously mentioned trial for children with cerebral palsy (NCT02866331), UCB plus G-CSF has been used for stroke patients (Shin and Cho, 2016), and adults with either a brain injury, cerebral palsy, Parkinson's disease or ALS (NCT02236065). Here, CSF3 is linked to stroke disorder.